Cornflakes Manufacturer To Reduce Glyphosate Use By 2025
Cornflakes Manufacturer To Reduce Glyphosate Use By 2025

Introduction
The manufacturer of Cornflakes and other popular cereal brands, Kellogg's, has committed to reducing the use of glyphosate as a pre-harvest desiccant in its major wheat and oat supply chains by 2025.
The manufacturer stated that they are working with their suppliers to completely phase-out glyphosate, the active ingredient of Roundup.
According to the results released by the Environmental Working Group, glyphosate was found in 45 of 47 kinds of cereal made from conventionally grown oats. The results revealed that the weed killer was present at levels the group considers unsafe for children. Following the testing conducted in 2018 and 2019, more than 310,000 consumers have signed a petition calling on Kellogg’s, General Mills, and Quaker to remove glyphosate from their products.
More than 40,000 lawsuits are filed against Roundup. The lawsuits are consolidated under federal multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation) in the Northern District of California, presided by U.S. District Judge Vince Chhabria.
Even Bayer published that it is facing 42,700 Roundup claims in its third-quarter report, but as per the reports, there are around 75,000 to 85,000 claims against the company seeking a settlement. Earlier, in December 2019, Bayer lost three trials in California, which resulted in a $191 million penalty for the company. It has requested to put further trials on hold, considering the losses.
Latest News
Talcum Powder Cancer Settlement Talks Begin Sept. 4
Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…
Tepezza Hearing Loss Trials Delayed Until Aug 2026
A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…
Cencora Directors Settle Opioid Oversight Case for $111M
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…